Generated by Meeveem AI
"Accelerating biomarker-driven drug development and commercial access to breakthrough treatments."
Precision Medicine Group integrates laboratory sciences, clinical expertise, and commercialisation services to accelerate drug development and market access. Operating through Precision for Medicine (biomarker research) and Precision AQ (commercialisation), the company employs 3,500 experts across 40 locations, supporting pharmaceutical firms in executing complex studies and navigating regulatory requirements. The company applies precision medicine principles to extract insights from patient biology and data, reducing timelines and improving treatment targeting. Services span specialty laboratories, clinical operations, market access, and medical communications, providing comprehensive support for bringing innovative medicines to patients.
3500
Team Members
2012
Founded
Contract Research
Sector
Hybrid
Work Environment
A healthcare system where patients receive treatments precisely matched to their biology, novel therapies reach those who need them without delay, and data-driven insights eliminate barriers between scientific innovation and human health.
At Precision Medicine Group, our mission is to transform the process of bringing new drugs to market by integrating science, technology, data, and human expertise to accelerate development and access to breakthrough treatments.